BRENTFORD, Britain (AP) _ GlaxoSmithKline PLC (GSK) on Wednesday reported first-quarter profit of $2.42 billion.
On a per-share basis, the Brentford, Britain-based company said it had net income of 96 cents.
WASHINGTON (AP) — GlaxoSmithKline’s IV drug for COVID-19 should no longer be used because it is likely ineffective against the omicron subvariant that now accounts for most U.S. cases, federal health regulators said Tuesday.
Canada has become the first country to authorize use of a plant-based COVID-19 vaccine.
Canadian regulators said Thursday Medicago’s two-dose vaccine can be given to adults ages 18 to 64, but said there's too little data on the shots in people 65 and older.
LONDON (AP) — Drugmakers Sanofi and GlaxoSmithKline said Wednesday they will seek regulatory approval for a new COVID-19 vaccine after human trials showed it provided a high level of protection against the disease.
LONDON (AP) — Unilever, the maker of Vaseline skin care products and Dove soap, says it won’t increase a 50 billion-pound ($68.2 billion) offer for GlaxoSmithKline’s consumer healthcare unit that was rejected last week.
LONDON (AP) — The pharmaceutical giant GlaxoSmithKline said Saturday it has rejected an unsolicited 50 billion-pound ($68.4 billion) bid from Unilever for its consumer healthcare goods unit, a joint venture it controls in a partnership with Pfizer.
WASHINGTON (AP) — As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are warning of yet another challenge: the two standard drugs they’ve used to fight infections are unlikely to work against the new strain.
A Canadian drugmaker said its plant-based COVID-19 vaccine showed strong protection against the virus and will soon seek authorization at home and elsewhere.
Medicago announced Tuesday that its two-dose vaccine was 71% effective at preventing COVID-19 infection in a large, late-stage study that included several variants including the delta variant.
AMSTERDAM (AP) — The European Union's medicines authority said Thursday that it is evaluating a new drug for treating COVID-19 patients who do not require extra oxygen but are at increased risk of developing severe symptoms of the disease.
LONDON (AP) — The World Health Organization on Wednesday endorsed the world's first malaria vaccine and said it should be given to children across Africa in the hope that it will spur stalled efforts to curb the spread of the parasitic disease.
PARIS (AP) — French drugmaker Sanofi said Tuesday it was shelving plans for a COVID-19 vaccine based on messenger RNA despite positive results from early stage testing.
The Paris-based company said it will continue to develop another vaccine candidate that is already undergoing late stage human trials.
Stocks that traded heavily or had substantial price changes Friday:
Alector Inc., up $12.80 to $35.21.
The biotechnology company is collaborating with GlaxoSmithKline to develop treatments for diseases including Parkinson’s disease and Alzheimer’s disease.
PARIS (AP) — Production of another potential vaccine against COVID-19 will begin within weeks, its developers Sanofi and GlaxoSmithKline said Thursday as they launched a large trial enrolling 35,000 adult volunteers in the United States, Asia, Africa and Latin America.
PARIS (AP) — Sanofi and GlaxoSmithKline’s potential COVID-19 vaccine triggered strong immune responses in all adult age groups in preliminary trials after an earlier setback, boosting optimism the shot may join the fight against the pandemic this year.
Shingrix, the recently approved vaccine for shingles, is hard to find these days.
A new vaccine to protect against a painful disease known as shingles is a victim of its own success and nearly impossible to find in Connecticut and many parts of the United States.
A research scientist from California pleaded guilty Friday in Philadelphia federal court to receiving trade secrets on anticancer research smuggled from pharmaceutical giant GlaxoSmithKline to bolster a fledgling but potential rival startup in China.
PHILADELPHIA (AP) — A Chinese scientist has pleaded guilty to conspiring to steal biopharmaceutical trade secrets from GlaxoSmithKline in what prosecutors said was a scheme to set up companies in China to market them...
U.S. regulators Friday approved a simpler, one-dose treatment to prevent relapses of malaria.
Standard treatment now takes two weeks and studies show many patients don't finish taking every dose...
CHICAGO (AP) — Two popular stop-smoking drugs are as safe for the heart as nicotine patches and dummy pills, according to research requested by U...